Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jayant Aphale currently holds 36,490 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jayant Aphale has been a net seller of SRPT stock. They have purchased $0 and sold $2.0M worth of shares.
Jayant Aphale's most recent insider trade was on Sep 19, 2016, when they sold 25,000 shares at $4.62 per share.
Jayant Aphale serves as Executive at Sarepta Therapeutics, Inc. (SRPT). They have executed 7 insider transactions totaling $2.0M over their tenure at the company.
Jayant Aphale holds the position of Executive at Sarepta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Jayant Aphale has shown a selling trading pattern, with $0 in total purchases and $2.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jayant Aphale was on Sep 19, 2016, when they sold $1.3M worth of SRPT shares. This transaction involved 25,000 shares at $50.00 per share.
Jayant Aphale currently owns 36,490 shares of Sarepta Therapeutics, Inc. (SRPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jayant Aphale's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jayant Aphale has 7 Form 4 filings on record as an insider at Sarepta Therapeutics, Inc..
Set alerts for Jayant Aphale and 40,000+ other insiders.